Diabetes Research Center, Traditional Chinese Medicine School, Beijing University of Chinese Medicine, Beijing 100029, China.
School of Chinese Material Medica, Beijing University of Chinese Medicine, Beijing 100029, China.
Phytomedicine. 2019 May;58:152871. doi: 10.1016/j.phymed.2019.152871. Epub 2019 Feb 18.
Salvia miltiorrhiza (SM), one of the frequently used herbs in traditional Chinese medicine (TCM), has now attracted rising interests for a possible alternative in the management of diabetes. This review is aimed to providing a comprehensive perspective of SM in phytochemical constituents, pharmacological activities against diabetes and its complications, and safety.
A comprehensive search of published literatures was conducted to locate original publications pertaining to SM and diabetes till the end of 2017 using PubMed, China National Knowledge Infrastructure, National Science and Technology Library, China Science and Technology Journal Database, and Web of Science database. The main inquiry was used for the presence of the following keywords in various combinations in the titles and abstracts: Salvia miltiorrhiza, diabetes, obesity, phytochemistry, pharmacology, and safety. About 200 research papers and reviews were consulted.
SM exhibited anti-diabetic activities by treating macro- and micro-vascular diseases in preclinical experiments and clinical trials through an improvement of redox homeostasis and inhibition of apoptosis and inflammation via the regulation of Wnt/β-catenin, TSP-1/TGF-β1/STAT3, JNK/PI3K/Akt, kinin B2 receptor-Akt-GSK-3β, AMPKβ/PGC-1α/Sirt3, Akt/AMPK, TXNIP/NLRP3, TGF-β1/NF-κB, mineralocorticoid receptor/Na/K-ATPase, AGEs/RAGE, Nrf2/Keap1, CaMKKβ/AMPK, AMPK/ACC, IRS-1/PI3K signaling pathways, and modulation of K-Ca channels, as well as influence of VEGF, NOS, AGEs, PPAR expression and hIAPP aggregation. The antidiabetic effects of this herb may be related to its TCM characters of improving blood circulation and reliving blood stasis. The main ingredients of SM included salvianolic acids and diterpenoid tanshinones, which have been well studied in the diabetic animals. Acute and subacute toxicity studies supported the notion that SM is well tolerated.
SM may offer a new strategy for prevention and treatment of diabetes and its complications that stimulates extensive research into identifying potential anti-diabetic compounds and fractions as well as exploring the underlying mechanisms of this herb. Further scientific evidences are still required from well-designed preclinical experiments and clinical trials on its anti-diabetic effects and safety.
丹参(SM)是一种常用于中药(TCM)的草药,现在因其在糖尿病管理方面的可能替代作用而引起了越来越多的关注。本综述旨在提供 SM 在植物化学成分、对糖尿病及其并发症的药理作用和安全性方面的全面视角。
使用 PubMed、中国知网、国家科技图书文献中心、中国科技期刊数据库和 Web of Science 数据库,全面检索了截至 2017 年底有关 SM 和糖尿病的已发表文献,检索词包括:丹参、糖尿病、肥胖、植物化学、药理和安全性。共查阅了约 200 篇研究论文和综述。
SM 通过改善氧化还原平衡,抑制细胞凋亡和炎症,通过调节 Wnt/β-catenin、TSP-1/TGF-β1/STAT3、JNK/PI3K/Akt、激肽 B2 受体-Akt-GSK-3β、AMPKβ/PGC-1α/Sirt3、Akt/AMPK、TXNIP/NLRP3、TGF-β1/NF-κB、醛固酮受体/Na/K-ATP 酶、AGEs/RAGE、Nrf2/Keap1、CaMKKβ/AMPK、AMPK/ACC、IRS-1/PI3K 信号通路以及调节 K-Ca 通道,以及影响 VEGF、NOS、AGEs、PPAR 表达和 hIAPP 聚集,在临床前实验和临床试验中表现出抗糖尿病作用,可治疗大血管和微血管疾病。这种草药的抗糖尿病作用可能与其改善血液循环和缓解血液淤滞的中医特征有关。SM 的主要成分包括丹参酸和二萜丹参酮,这些成分在糖尿病动物中得到了很好的研究。急性和亚急性毒性研究支持了 SM 耐受良好的观点。
SM 可能为糖尿病及其并发症的防治提供新策略,这激发了广泛的研究,以确定潜在的抗糖尿病化合物和馏分,并探索这种草药的潜在机制。还需要更多来自设计良好的临床前实验和临床试验的科学证据,以证明其抗糖尿病作用和安全性。